Medical Groups Challenge Federal Marijuana Rescheduling Over Drug Safety Concerns

Washington, Thursday, 5 November 2026.
Medical leaders and former drug officials are challenging federal marijuana reclassification, arguing that expanding commercial access without standard clinical trials risks patient safety.